| Literature DB >> 24452252 |
Marieta Braks1, Rijk van Ginkel2, William Wint3, Luigi Sedda4, Hein Sprong5.
Abstract
Public health authorities are required to prepare for future threats and need predictions of the likely impact of climate change on public health risks. They may get overwhelmed by the volume of heterogeneous information in scientific articles and risk relying purely on the public opinion articles which focus mainly on global warming trends, and leave out many other relevant factors. In the current paper, we discuss various scientific approaches investigating climate change and its possible impact on public health and discuss their different roles and functions in unraveling the complexity of the subject. It is not our objective to review the available literature or to make predictions for certain diseases or countries, but rather to evaluate the applicability of scientific research articles on climate change to evidence-based public health decisions. In the context of mosquito borne diseases, we identify common pitfalls to watch out for when assessing scientific research on the impact of climate change on human health. We aim to provide guidance through the plethora of scientific papers and views on the impact of climate change on human health to those new to the subject, as well as to remind public health experts of its multifactorial and multidisciplinary character.Entities:
Mesh:
Year: 2013 PMID: 24452252 PMCID: PMC3924434 DOI: 10.3390/ijerph110100013
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Public health related characteristics of important mosquito borne diseases.
| Disease | Annual Global Cases 1 | Pathogen | Vector Genus | Infectious Period | Prophylaxis | Vaccine | Curative Medicine |
|---|---|---|---|---|---|---|---|
| Malaria | 451 million 2 |
|
| Up to year 7 | √ | - | √ |
| Dengue | 96 million 3 | Flavivirus |
| 3–5 days | - | - | - |
| Yellow fever | 200,000 4 | Flavivirus |
| 3–5 days | - | √ | - |
| Japanese Encephalitis | 67,900 5 | Flavivirus |
| dead end host | - | √ | - |
| West Nile fever | 20, 000 6 | Flavivirus |
| dead end host | - | - 9 | - |
| Chikungunya | Epidemic | Alphavirus |
| 6–7 days | - | - | - |
| Rift Valley fever | Epidemic | Phlebovirus |
| short 8 | - | - | - |
Note: 1 Case estimates, exact numbers not available; 2 [1,2]; 3 [3] Clinical cases only, ¾ of dengue infections are apparent; 4 Who Factsheet N° 100 May 2013; 5 [4]; 6 [5]; 7 Depending on Plasmodium species but when untreated up to a year, exception of Plasmodium vivax with prolonged incubation period up to 5 years; 8 [6] Humans theoretical reservoir (low epidemiological significance); 9 Veterinary vaccines available for horses.
Figure 1Schematic representation of the transmission cycles of (a) dengue virus, (b) Rift valley fever virus, (c) West Nile fever virus.
Current situations of mosquito borne diseases for Western Europe, here delimited by Belgium, Netherlands and UK [55,56].
| Context | Locally Acquired Human Case | Pathogen | Vector | Mosquito Borne Diseases in Western Europe |
|---|---|---|---|---|
| 1a | √ (every year) | √ | √ |
|
| 1b | √ (not every year) | √ | √ |
|
| 2 |
| √ | √ | Heartworm [ |
| 3 |
| - | √ | West Nile virus [ |
| 4 |
| √ | - | Chikungunya; Dengue [ |
| 5 |
| - | - | Japanese encephalitis * |
Note: * Potentially European mosquitoes are competent to transmit JEV [64], but this has not been validated.